{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:14:40Z","timestamp":1789906480103,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.vaccine.2010.08.012","type":"journal-article","created":{"date-parts":[[2010,8,14]],"date-time":"2010-08-14T09:02:05Z","timestamp":1281776525000},"page":"6675-6683","source":"Crossref","is-referenced-by-count":44,"title":["Vaccines delivered by integration-deficient lentiviral vectors targeting dendritic cells induces strong antigen-specific immunity"],"prefix":"10.1016","volume":"28","author":[{"given":"Biliang","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingbing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.08.012_bib0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1146\/annurev.genom.2.1.177","article-title":"Gene therapy: promises and problems","volume":"2","author":"Pfeifer","year":"2001","journal-title":"Annu Rev Genom Hum G"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0010","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.272.5259.263","article-title":"In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector","volume":"272","author":"Naldini","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0015","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.pharmtox.43.100901.140257","article-title":"Gene therapy with viral vectors","volume":"43","author":"Kootstra","year":"2003","journal-title":"Annu Rev Pharmacol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0025","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nm1039","article-title":"Dendritic cell immunotherapy: mapping the way","volume":"10","author":"Figdor","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0030","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nature06175","article-title":"Taking dendritic cells into medicine","volume":"449","author":"Steinman","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jgm.846","article-title":"From pathogen to medicine: HIV-1-derived lentiviral vectors as vehicles for dendritic cell based cancer immunotherapy","volume":"8","author":"Dullaers","year":"2006","journal-title":"J Gene Med"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0040","first-page":"451","article-title":"Lentiviral transduction of human dendritic cells","volume":"246","author":"Schroers","year":"2004","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0045","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1089\/104303402753812494","article-title":"Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors","volume":"13","author":"Esslinger","year":"2002","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0050","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1089\/hum.2005.16.1255","article-title":"Induction of therapeutic antitumor immunity by in vivo administration of a lentiviral vaccine","volume":"16","author":"Kim","year":"2005","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0055","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/sj.gt.3302697","article-title":"Induction of effective therapeutic antitumor immunity by direct in vivo administration of lentiviral vectors","volume":"13","author":"Dullaers","year":"2006","journal-title":"Gene Ther"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0060","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1016\/j.vaccine.2009.01.055","article-title":"Lentiviral vectors for HIV disease prevention and treatment","volume":"27","author":"Lemiale","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0065","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nbt1390","article-title":"Engineered lentivector targeting of dendritic cells for in vivo immunization","volume":"26","author":"Yang","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0070","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nbt1216","article-title":"Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration","volume":"24","author":"Montini","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0075","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1128\/JVI.01865-08","article-title":"Insertional gene activation by lentiviral and gammaretroviral vectors","volume":"83","author":"Bokhoven","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0080","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1126\/science.1088547","article-title":"LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1","volume":"302","author":"Hacein-Bey-Abina","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0085","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ymthe.2006.03.001","article-title":"Genotoxicity of retroviral integration in hematopoietic cells","volume":"13","author":"Nienhuis","year":"2006","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0090","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1038\/mt.2009.122","article-title":"Integration-deficient lentiviral vectors: a slow coming of age","volume":"17","author":"Wanisch","year":"2009","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/hum.2007.013","article-title":"Use of nonintegrating lentiviral vectors for gene therapy","volume":"18","author":"Philpott","year":"2007","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0100","doi-asserted-by":"crossref","first-page":"17684","DOI":"10.1073\/pnas.0606197103","article-title":"Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo","volume":"103","author":"Philippe","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0105","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nm1365","article-title":"Effective gene therapy with nonintegrating lentiviral vectors","volume":"12","author":"Yanez-Munoz","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0110","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1038\/sj.mt.6300281","article-title":"Stable gene transfer to muscle using non-integrating lentiviral vectors","volume":"15","author":"Apolonia","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0115","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1038\/mt.2008.199","article-title":"A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector","volume":"16","author":"Bayer","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0120","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1038\/sj.mt.6300241","article-title":"Successful immunization with a single injection of non-integrating lentiviral vector","volume":"15","author":"Negri","year":"2007","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0125","doi-asserted-by":"crossref","first-page":"e3973","DOI":"10.1371\/journal.pone.0003973","article-title":"Protective antiviral immunity conferred by a nonintegrative lentiviral vector-based vaccine","volume":"3","author":"Coutant","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0130","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1128\/JVI.02519-08","article-title":"Nonintegrating lentivector vaccines stimulate prolonged T-cell and antibody responses and are effective in tumor therapy","volume":"83","author":"Karwacz","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0135","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1089\/hum.2009.012","article-title":"Nonintegrating lentiviral vectors can effectively deliver ovalbumin antigen for induction of antitumor immunity","volume":"20","author":"Hu","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0140","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/JVI.70.2.721-728.1996","article-title":"Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection","volume":"70","author":"Leavitt","year":"1996","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0145","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1126\/science.1067081","article-title":"Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors","volume":"295","author":"Lois","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0150","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0155","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1472-6750-6-34","article-title":"Comparison of lentiviral vector titration methods","volume":"6","author":"Geraerts","year":"2006","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0160","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/87979","article-title":"A quantitative assay for HIV DNA integration in vivo","volume":"7","author":"Butler","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0092-8674(94)90169-4","article-title":"T cell receptor antagonist peptides induce positive selection","volume":"76","author":"Hogquist","year":"1994","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0170","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1440-1711.1998.00709.x","article-title":"Defective TCR expression in transgenic mice constructed using cDNA-based alpha- and beta-chain genes under the control of heterologous regulatory elements","volume":"76","author":"Barnden","year":"1998","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0175","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/104303404322959515","article-title":"Novel integrase-defective lentiviral episomal vectors for gene transfer","volume":"15","author":"Vargas","year":"2004","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0180","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1128\/JVI.78.6.2906-2920.2004","article-title":"Unintegrated lentivirus DNA persistence and accessibility to expression in nondividing cells: analysis with class I integrase mutants","volume":"78","author":"Saenz","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1146\/annurev.immunol.16.1.201","article-title":"T cell memory","volume":"16","author":"Dutton","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1006\/mthe.2000.0029","article-title":"Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens","volume":"1","author":"Perricone","year":"2000","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0200","doi-asserted-by":"crossref","first-page":"20382","DOI":"10.1073\/pnas.0911742106","article-title":"HIV-1 Gag-specific immunity induced by a lentivector-based vaccine directed to dendritic cells","volume":"106","author":"Dai","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0205","first-page":"279","article-title":"DC-SIGN and immunoregulation","volume":"3","author":"Zhou","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0210","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1084\/jem.183.4.1865","article-title":"A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph","volume":"183","author":"Matsuno","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2010.08.012_bib0215","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1128\/JVI.72.6.4678-4685.1998","article-title":"Mutations in the human immunodeficiency virus type 1 integrase D,D(35)E motif do not eliminate provirus formation","volume":"72","author":"Gaur","year":"1998","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10011217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T13:11:21Z","timestamp":1591794681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10011217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":43,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0264410X10011217"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.08.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}